Figure 3.
Cellular proliferation marker expression classified according to SPATA18 expression. (a), SPATA18-high tumors contained a significantly higher number of PHH3-positive cells. (b), CCNA labeling index was significantly higher in SPATA18-high tumors. (c,d), No significant difference was detected in GMNN or Ki-67 labeling indices in SPATA18-high and -low tumors.